Remove companies chemocentryx-inc
article thumbnail

ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why

Benzinga

Shares of ChemoCentryx, Inc. NASDAQ: CCXI ) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. A ChemoCentryx press release announced that Amgen, Inc. NASDAQ: AMGN ) has acquired the company in an all-cash deal. Why Is It Moving? amid the announcement.

article thumbnail

Wachtell, Latham & Watkins Steer $3.7B Biopharma Deal

Law 360 M&A

Biotechnology company Amgen Inc., led by Wachtell Lipton Rosen & Katz, will purchase Latham & Watkins LLP-steered biopharmaceutical company ChemoCentryx Inc., billion, the companies announced Thursday. for an enterprise value of $3.7